Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Researchers use 3-D imaging to identify proteins involved in arterial stiffness

Human arteries - some smaller than a strand of hair - stiffen as a person ages. This stiffening is a factor in cardiovascular disease, the leading cause of death in the United States, because it contributes to the circulatory complications in disorders such as high blood pressure and diabetes. University of Missouri researchers have now used advanced 3-D microscopic imaging technology to identify and monitor the proteins involved in this stiffening process.

10 Jan 2012

Study demonstrates that individuals can eat out and still lose weight

Going out to eat has become a major part of our culture. Frequently eating out and consuming high-calorie foods in large portions at restaurants can contribute to excess calorie intake and weight gain. However, a study in the January/February 2012 issue of the Journal of Nutrition Education and Behavior demonstrates that individuals can eat out and still lose weight.

10 Jan 2012

Study identifies netrin-1 as novel target for atherosclerosis

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries. The research, published online by Nature Immunology on January 8, 2012, explains why cholesterol-laden, coronary artery disease-causing cells called macrophages, accumulate in artery plaques.

10 Jan 2012

JHM, Healthways partner for innovative weight-loss program

Building on the success of recent Hopkins research showing obese participants were able to lose significant weight and keep it off for two years using telephone coaching and a specially designed website, Johns Hopkins Medicine is collaborating with Healthways to help bring the innovative weight-loss program to many more who could benefit from it.

9 Jan 2012

Novel target in artery plaque identified as potential therapeutic intervention

A new study by NYU Langone Medical Center researchers identified a new culprit that leads to atherosclerosis, the accumulation of fat and cholesterol that hardens into plaque and narrows arteries.

9 Jan 2012

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.

9 Jan 2012

Middle-aged adults with diabetes have time to learn how to control hypertension

A new study suggests that middle-aged adults recently diagnosed with diabetes and hypertension have time to try to learn how to control their high blood pressure without medications, but not too much time.

9 Jan 2012

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces that it has signed an agreement with miRagen Therapeutics, Inc., to assess the delivery potential of Silence's proprietary DBTC delivery system with miRagen's novel microRNA-based therapeutics.

9 Jan 2012

Statin use may influence susceptibility to ILD in smokers

Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study.

6 Jan 2012

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

5 Jan 2012

Repeated episodes of depression contribute to inflammation

An important ongoing debate in the field of psychiatry is whether inflammation in the body is a consequence of or contributor to major depression. A new study in Biological Psychiatry has attempted to resolve the issue.

5 Jan 2012

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive preliminary results from its ongoing clinical trial of ALN-PCS, an RNAi therapeutic targeting PCSK9 for the treatment of severe hypercholesterolemia.

5 Jan 2012

Re-admission rates high among U.S. heart attack patients: Study

According to new research from U.S health experts, Americans who have a severe form of a heart attack are far more likely to be readmitted to the hospital than people from 16 other countries with the same kind of heart attack.

4 Jan 2012

Weight loss surgery cuts risk of heart attacks, strokes: Study

A new study shows that weight loss surgery clearly cuts the risk of heart attacks, strokes and death from cardiovascular disease. But the research also raises questions regarding which patients benefit the most from surgery.

4 Jan 2012

Genomic architecture predisposes supercentenarians to age-related diseases

The first-ever published whole-genome sequences of not just one, but two supercentenarians, aged more than 114 years, reveal that both unusual and common genetic phenomena contribute to the genetic background of extreme human longevity.

4 Jan 2012

Osiris provides update on Prochymal Phase 2 trial for type 1 diabetes

Osiris Therapeutics, Inc., today provided an update on its Phase 2 trial evaluating Prochymal, a formulation of adult mesenchymal stem cells (MSCs), in patients with newly diagnosed type 1 diabetes.

4 Jan 2012

Sex, race and dementia may influence risk of mortality in patients with PD

Demographics and clinical factors appear to be associated with survival in patients with Parkinson disease (PD), and the presence of dementia is associated with a significant increase in mortality, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals.

2 Jan 2012

Major European medical center includes Critical Diagnostics' Presage ST2 Assay for cardiac care

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that a major European medical center, Hospital Germans Trias i Pujol in Barcelona Spain, is now using the company's Presage ST2 Assay for routine care and management of their heart failure patients.

2 Jan 2012

Britain mulling on cigarette plain packaging to discourage smoking

Britain wishes to follow Australia’s footsteps in banning all eye-catching designs and branding from cigarette packs to stop young people being lured into smoking. Australia meanwhile is poised to become the first nation to introduce so-called “plain” packaging on tobacco products by the end of 2012. The packs will show graphic health warnings about smoking but banish attractive colors and logos. The proposed law was cleared by parliament in November and is being closely watched by governments considering similar moves in Europe, Canada and New Zealand.

1 Jan 2012

Meta-analysis does not find significant association between CYP2C19 genotype and cardiovascular events

Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events.

28 Dec 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Researchers use 3-D imaging to identify proteins involved in arterial stiffness

Study demonstrates that individuals can eat out and still lose weight

Study identifies netrin-1 as novel target for atherosclerosis

JHM, Healthways partner for innovative weight-loss program

Novel target in artery plaque identified as potential therapeutic intervention

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Middle-aged adults with diabetes have time to learn how to control hypertension

miRagen, Silence partner to assess delivery potential of novel miRNA-based therapeutics

Statin use may influence susceptibility to ILD in smokers

CRF sponsors Seventh International Conference on Cell Therapy for Cardiovascular Disease

Repeated episodes of depression contribute to inflammation

Positive preliminary results from Alnylam's Phase I ALN-PCS trial on severe hypercholesterolemia

Re-admission rates high among U.S. heart attack patients: Study

Weight loss surgery cuts risk of heart attacks, strokes: Study

Genomic architecture predisposes supercentenarians to age-related diseases

Osiris provides update on Prochymal Phase 2 trial for type 1 diabetes

Sex, race and dementia may influence risk of mortality in patients with PD

Major European medical center includes Critical Diagnostics' Presage ST2 Assay for cardiac care

Britain mulling on cigarette plain packaging to discourage smoking

Meta-analysis does not find significant association between CYP2C19 genotype and cardiovascular events

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in